FOI-27-3502, 27-3520, 27-3521, 27-3522, 27-3523, 27-3524, 27-3525, 27-3526, 27-3527, 27-3528, 27-3529, 27-3530 – Estimates briefs

Written by Claude Haiku 5.5 from the extracted text on 23 Oct 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

This FOI release comprises estimates briefing material for the Senate Community Affairs Committee's 2026-27 Budget Estimates, covering the Department of Health, Disability and Ageing (Outcome 0, Whole of Portfolio). Contents include workforce data (average staffing levels rising from 6,159 in 2023-24 to 7,085 in 2025-26, turnover, remote work agreements and personal leave), departmental travel expenditure from 2019-20 to 2025-26, consultancy and contractor lists with values, budget measures and corrigenda to portfolio budget and supplementary estimates statements, NDIS reform and public hospital funding ($24.4 billion under the NHRA), and a women's health package. The women's health material lists PBS listings from March to May 2025, including Yaz, Yazmin, Estrogel, Prometrium, Slinda and Ryeqo, with $443.4 million allocated to PBS listings. No TGA evaluations, clinical efficacy or safety data, or cost-effectiveness assessments are evident in the excerpt.